Martin Kulldorff

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Health Information

Infectious Diseases

Extracorporeal Membrane Oxygenation

Rheumatoid Arthritis Patients

Top Venues

JMIR public health and surveillance

Statistics in medicine

Pharmacoepidemiology and drug safety

Harvard Medical School and Brigham and Women's Hospital

Cornell University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Harvard Medical School and Brigham and Women's Hospital

United States

Professor :: Depertment of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics

Education History

Cornell University

United States

PHD :: Opeartions Research and Industrial Engineering

Publications

Alison Levin-Rector, Martin Kulldorff, Eric R Peterson, Scott Hostovich, Sharon K Greene
Prospective Spatiotemporal Cluster Detection Using SaTScan: Tutorial for Designing and Fine-Tuning a System to Detect Reportable Communicable Disease Outbreaks. JMIR public health and surveillance 10 (2024)
Alison Levin-Rector, Martin Kulldorff, Eric R Peterson, Scott Hostovich, Sharon K Greene
Prospective Spatiotemporal Cluster Detection Using SaTScan: Tutorial for Designing and Fine-Tuning a System to Detect Reportable Communicable Disease Outbreaks. JMIR public health and surveillance 10 (2024)
Alison Levin-Rector, Martin Kulldorff, Eric R Peterson, Scott Hostovich, Sharon K Greene
Prospective Spatiotemporal Cluster Detection Using SaTScan: Tutorial for Designing and Fine-Tuning a System to Detect Reportable Communicable Disease Outbreaks. JMIR public health and surveillance 10 (2024)
Ivair R Silva, Joshua J Gagne, Mehdi Najafzadeh, Martin Kulldorff
Exact sequential analysis for multiple weighted binomial end points. Statistics in medicine 39 (3) (2019)
Shirley V Wang, Martin Kulldorff, Robert J Glynn, Joshua J Gagne, Jesper Hallas, Kenneth J Rothman, Sebastian G Schneeweiss, Alexander Muir Walker
Reuse of data sources to evaluate drug safety signals: When is it appropriate? Pharmacoepidemiology and drug safety 27 (6) (2018)